<DOC>
	<DOCNO>NCT01848171</DOCNO>
	<brief_summary>Hypothyroidism common clinical entity often complicate dyslipidemia . It also report increased risk incidence atherosclerosis result coronary heart disease ( CHD ) , heart failure ( HF ) cardiovascular ( CV ) death . The effect L-thyroxine replacement treatment serum lipid atherosclerosis controversial hypothyroid patient , especially mild moderate subclinical hypothyroidism . The present study design investigate whether L-thyroxine replacement effective improve serum lipid profile retard atherosclerosis progress .</brief_summary>
	<brief_title>Effects L-thyroxine Replacement Serum Lipid Atherosclerosis Hypothyroidism</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<criteria>40~75 year old Diagnosis overt subclinical hypothyroidism two occasion minimum interval period three month Pregnant lactate woman Severe hepatic renal dysfunction Psychiatric disability , acute cardiovascular cerebrovascular disease , chronic respiratory disease , familiar hypercholesterolemia , malignancy , cholelithiasis , pancreatitis , bowel disease disorder influence lipid bile acid metabolism Taking lipidlowering agent drug influence thyroid function , lipid bile acid metabolism Obviously poor compliance .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hypothyroidism</keyword>
	<keyword>Lipid</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Chronic Inflammation</keyword>
	<keyword>Endothelial Function</keyword>
	<keyword>Adipocytokine</keyword>
	<keyword>L-thyroxine</keyword>
</DOC>